[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100313569":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":21,"responsibleParty":40,"collaborators":43,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":7,"enrollmentInfo":60,"targetDuration":7,"studyType":63,"phases":7,"briefSummary":64,"conditions":65,"keywords":70,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Wuerzburg University Hospital","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Peter Nordbeck, MD, PhD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","004993120139181","nordbeck_p@ukw.de",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Jonas Muentze, MD","004993120139958","muentze_j@ukw.de",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Würzburg","Bavaria","97080","Germany","DE",{"type":30,"coordinates":31},"Point",[32,33],9.95121,49.79391,{"lat":33,"lon":32},[36],{"name":37,"role":14,"phone":38,"phoneExt":7,"email":39},"Irina Schumacher","004993120139714","schumacher_i@ukw.de",{"type":11,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PD Dr. Peter Nordbeck","Head Consultant Cardiology and Chief of Electrophysiology",[44,46,48],{"name":45,"class":6},"Competence Network Heart Failure",{"name":47,"class":6},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)",{"name":49,"class":6},"St George's, University of London","100313569","evaluation-of-heart-involvement-in-patients-with-fabry-disease-100313569",false,"NCT03362164","Evaluation of HEArt invoLvement in Patients With FABRY Disease","Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease","HEAL-FABRY","Inclusion Criteria:\n\n* Fabry disease (genetically confirmed)\n* Signed informed consent\n* 18 years and older\n\nExclusion Criteria:\n\n* No informed consent\n* Withdrawal of informed consent","ALL","18 Years",{"count":61,"type":62},650,"ESTIMATED","OBSERVATIONAL","This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.",[66,67,68,69],"Rare Diseases","Fabry Disease","Fabry Disease, Cardiac Variant","Hypertrophic Cardiomyopathy",[71,72,73,74,75],"Fabry","Fibrosis","Dialysis","Stroke","Chronic kidney disease","2022-07-06",{"date":78,"type":79},"2022-07-07","ACTUAL",{"date":81,"type":79},"2001-01",{"date":83,"type":62},"2032-03",{"name":5,"class":6},1]